MSFT241108C510000
- 0.01
- -0.01-50.00%
Microsoft Newsroom
Market Chatter: Microsoft-Backed OpenAI in Talks With Regulator to Become For-Profit Company
Sector Update: Tech Stocks Gain Tuesday Afternoon
Microsoft Co-Founder Bill Gates Says Everyone In Future Will Have A 'Utilitarian AI Agent' That Will Help You At Work
Analysts Tout an 'Underappreciated Growth Driver' at Microsoft That Can Benefit From AI
We Want YOU to Submit Questions for Election Night
Here Is How Investors Can Capture Opportunities From The Election
Wall Street's 'Fear Gauge' Spiked Before Election Day. It Could Be a Buying Opportunity. -- Barrons.com
Hyperscaler Capex Forecasts to Hit $300B in 2025: Morgan Stanley
Microsoft Analyst Ratings
Market Climbs for Election Day Excitement | Live Stock
Republican Win Likely To Lift Magnificent 7 Stocks, Democratic Sweep 'Better For Bonds,' Says WisdomTree
Meta's Former Orion Chief Joins OpenAI to Lead Robotics Efforts
AI Robot Trader Dumped Microsoft, Amazon Stocks and Went Defensive. Here's What It Bought. -- Barrons.com
Market Clubhouse Morning Memo - November 5th, 2024 (Trade Strategy For SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META And TSLA)
Will IBM's Expanded Capabilities in Microsoft Cloud Aid the Stock?
Clarra Expands Case Management Capabilities to Modernize Litigation Management
Martello Launches Partner Network to Drive New Growth and Profit Opportunities for Microsoft 365 Partners
Dow's 118-Point Rally Led By Gains For Shares Of Intel, American Express
Morgan Stanley Maintains Microsoft(MSFT.US) With Buy Rating, Maintains Target Price $548
Tevogen Bio Leverages Microsoft Partnership To Deliver Machine Learning Based Target Identification To Address HPV, Advancing TVGN 920